|
MTNB Matinas Biopharma Holdings Inc 1582554 |
| Income Statement |
|
Net Income
|
form10-q
|
-4,275,000 |
| Balance Sheet |
|
Current Assets
|
11,741,000 |
|
Assets
|
20,577,000 |
|
Current Liabilities
|
2,124,000 |
|
Liabilities
|
4,798,000 |
|
Equity
|
15,779,000 |
|
Shares Out
|
5,016,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-12,375,000 |
|
Investing Cash Flow
|
8,708,000 |
| Market Analysis |
Market Cap
|
18,184,167 |
|
Price
|
0.56 |
|
BVPS
|
3.15 |
|
PB
|
0.17 |
|
EPS
|
-5.10 |
|
PS
|
1.47 |
|
FCF
|
-3,667,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view MTNB documents filed with the SEC.
MTNB Filings
Clear
